A stakeholder working group organized by the Board has prepared best practices on providing access to prescription drug container labels for people who are blind or visually impaired or who are elderly. This information is advisory only, not mandatory.  It was developed under the “Food and Drug Administration Safety and Innovation Act" which directed the Board to organize the working group.

Next Steps

Additional action will be undertaken by other agencies as directed by the Act:

Stakeholder Working Group Recommendations and Related Information